Iodine 125 interstitial irradiation for localized prostate cancer

Area of Science:

• Oncology
• Radiation Oncology
• Urology

Background:

• Localized prostate cancer treatment traditionally involves radical surgery or external beam radiation therapy.
• Permanent interstitial brachytherapy presents an alternative therapeutic approach.
• Transperineal percutaneous template-guided brachytherapy is an evolving technique for prostate cancer management.

Purpose of the Study:

• To present the technique and assess the 5-year outcomes of transperineal percutaneous template permanent interstitial iodine 125 endocurietherapy.
• To evaluate complications associated with this brachytherapy method.
• To compare the 5-year results with established treatments like radical surgery and external beam radiation therapy.

Main Methods:

• Retrospective analysis of 85 patients with localized prostate cancer treated with transperineal iodine 125 permanent interstitial endocurietherapy.
• Detailed documentation of the implantation technique and procedural complications.
• Long-term follow-up to assess 5-year oncological and safety outcomes.

Main Results:

• The 5-year oncological outcomes were found to be similar to those achieved with external beam radiation therapy or radical prostatectomy.
• Significant reductions in iatrogenic mortality and morbidity were observed compared to conventional treatments.
• Treatment duration and hospitalization periods were also significantly decreased.

Conclusions:

• Transperineal permanent interstitial iodine 125 endocurietherapy is a viable treatment option for localized prostate cancer.
• This technique demonstrates comparable efficacy to established treatments with a significantly improved safety profile.
• The reduced treatment time and hospitalization offer patient benefits and potential healthcare cost savings.